MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-17-0035249
Unimax Laboratories Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.14 Cr
▲ 19% YoY
Net profit · FY 2025
₹1 Cr
Net margin 9%
EBITDA · FY 2025
₹2.24 Cr
EBITDA margin 20.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹6.75 Cr
Secured borrowings
Company age
41 yrs
Est. 1985
Employees · EPFO
12
Provident fund records
About Unimax Laboratories Private Limited
Data last updated:
Unimax Laboratories Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 January 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH1985PTC035004. Its GSTIN is 27AAACE6243J1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹70 Lakh. It was formerly known as Eastern Remedies P Ltd. It is led by directors including Kaushik Ramanlal Shah (Managing Director) and Piyush Suresh Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at W – 50 (B) M.I.D.C. Tarapur Boisar, Thane, Maharashtra, India – 401506.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.14 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1 Cr (net margin 9%) and EBITDA of ₹2.24 Cr (EBITDA margin 20.1%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 10% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6.75 Cr on record.
Unimax Laboratories Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-17-0035249). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unimax.co.in.
Company details
CIN U24110MH1985PTC035004
Registration Number 035004
Incorporation Date 05 January 1985
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-17-0035249
Key People
Kaushik Ramanlal Shah Managing Director Piyush Suresh Shah Director Brijesh Yashwant Shah Director Recognitions & Rankings of Unimax Laboratories
Contact details
Unimax Laboratories Private Limited's registered office is in Thane, Maharashtra. Its website is unimax.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressW – 50 (B) M.I.D.C. Tarapur Boisar, Thane, Maharashtra, India – 401506
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Unimax Laboratories Private Limited, buy the company report.
Comprehensive company report
Unimax Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Unimax Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Unimax Laboratories Private Limited, buy the company report.
Financials of Unimax Laboratories Private Limited
FY 2025 filings availableUnimax Laboratories Private Limited reported revenue of ₹11.14 Cr (up 19% YoY) for FY 2025.
Revenue · FY 2025
₹11.14 Cr ▲ 19%
Net profit · FY 2025
₹1 Cr margin 9%
EBITDA · FY 2025
₹2.24 Cr margin 20.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 3%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 89%
3 years · compounded
▼ 2%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 19% growth in the latest year. EBITDA rose 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.1% | ||||
| Net Profit Margin | 9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unimax Laboratories Private Limited, buy the company report.
Board of directors of Unimax Laboratories Private Limited
Unimax Laboratories has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Piyush Suresh Shah | Director | 01 Jul 1999 | 27 Years 3 Months | Current |
| Brijesh Yashwant Shah Also directs: Unimax Chemicals Private Limited | Director | 01 Jul 1999 | 27 Years 3 Months | Current |
| Kaushik Ramanlal Shah Also directs: Unimax Chemicals Private Limited | Managing Director | 01 Jul 1985 | 41 Years 3 Months | Current |
Peer comparison
Unimax Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Empree Medicaments (India) Private Limited | ₹11.19 Cr (FY 2024) | -31.0% | Mumbai, Maharashtra, India | |||
| Navketan Pharma Pvt Ltd | ₹11.17 Cr (FY 2024) | 55.0% | Aurangabad, Maharashtra, India | |||
| Unimax Laboratories Private Limitedthis company | ₹11.14 Cr (FY 2025) | ₹1 Cr | 9% | 19.0% | 12 | Thane, Maharashtra, India |
| Sunglow Pharmaceuticalss Private Limited | ₹11.14 Cr (FY 2025) | -16.0% | Puducherry, India | |||
| Cygnus Pharmaceuticals Private Limited | ₹11.13 Cr (FY 2018) | -36.0% | Kolkata, West Bengal, India | |||
| VC Laboratories Private Limited | ₹11.12 Cr (FY 2018) | -21.0% | Hyderabad, Telangana, India | |||
| Sovereign Remedies Pvt. Ltd. | ₹11.11 Cr (FY 2016) | 26.0% | Indore, (M.P..), Madhya Pradesh, India |
To see the full peer comparison of Unimax Laboratories Private Limited, buy the company report.
Auditor
Unimax Laboratories Private Limited is audited by NATHVANI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NATHVANI & ASSOCIATES | FY 2022 | 138702W |
Shareholding
The shareholding of Unimax Laboratories Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unimax Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Sep 2006 | 10107928 | Bank of Baroda | ₹3.05 Cr | Open | |
| 06 Sep 2006 | 10101960 | Bank of Baroda | ₹3.7 Cr | Open |
To see the full charge records of Unimax Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Unimax Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Unimax Laboratories Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 159 overdue payments to 38 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 38)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sadekar Enviro Engineers Private Limited | |||
| an individual supplier | |||
| Penta Freight Private Limited | |||
| an individual supplier | |||
| Artha Enterprise |
To see the full MSME payment records of Unimax Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Unimax Laboratories Private Limited has a workforce of 12 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
GST
Unimax Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACE6243J1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unimax Laboratories Private Limited, buy the company report.
Recent activity
Unimax Laboratories Private Limited has 6 board changes on record since 1985: 3 appointments and 3 cessations. The latest: Anil Balkrishna Ghogare ceased to be Director on 14 Feb 2025.
AGM
Unimax Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Unimax Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Anil Balkrishna Ghogare ceased to be Director.
Ceased
Yashwant Ramanlal Shah ceased to be Director.
Ceased
Suresh Ramanlal Shah ceased to be Director.
Charges
A charge with Bank Of Baroda of Rs. 3.70 Cr registered on 06 Sep 2006 with Charge ID 10101960 was modified on 13 Feb 2014.
Charges
A charge with Bank Of Baroda of Rs. 3.05 Cr registered on 07 Sep 2006 with Charge ID 10107928 was modified on 03 Jan 2011.
Charges
A charge with Bank Of Baroda amounted to Rs. 3.05 Cr with Charge ID 10107928 was registered on 07 Sep 2006.
Charges
A charge with Bank Of Baroda amounted to Rs. 3.70 Cr with Charge ID 10101960 was registered on 06 Sep 2006.
Appointed
Brijesh Yashwant Shah was appointed as Director.
Appointed
Piyush Suresh Shah was appointed as Director.
Appointed
Kaushik Ramanlal Shah was appointed as Managing Director.
1 earlier event is in the company report.
Frequently asked questions
Unimax Laboratories is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 January 1985 (41+ years old) and is registered under CIN U24110MH1985PTC035004.
Unimax Laboratories has 3 current directors:
- Kaushik Ramanlal Shah - Managing Director
- Piyush Suresh Shah - Director
- Brijesh Yashwant Shah - Director
The latest financial statements of Unimax Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unimax Laboratories is 27AAACE6243J1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Unimax Laboratories is U24110MH1985PTC035004. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unimax Laboratories was incorporated on 05 January 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Unimax Laboratories by revenue are Empree Medicaments (India) Private Limited, Navketan Pharma Pvt Ltd, Sunglow Pharmaceuticalss Private Limited, Cygnus Pharmaceuticals Private Limited, VC Laboratories Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Balkrishna Ghogare ceased to be Director on 14 Feb 2025. Yashwant Ramanlal Shah ceased to be Director on 09 Aug 2024. Suresh Ramanlal Shah ceased to be Director on 10 Jun 2015. Unimax Laboratories has 6 board changes on record in total.
Yes, Unimax Laboratories is registered as an MSME under Udyam registration (number: UDYAM-MH-17-0035249).
Unimax Laboratories has 14 MSME Form 1 returns on record between 2019 and 2023, listing 159 overdue payments to 38 micro and small suppliers. The latest return was filed on 28 Apr 2023.
Unimax Laboratories can be reached through the website unimax.co.in. Its registered office is in Thane, Maharashtra, India.
The registered office of Unimax Laboratories is at W – 50 B M.I.D.C. Tarapur Boisar, Thane, Maharashtra, India – 401506.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages